Hims and Hers first announced its expansion into Canada in early July, taking the opportunity as Danish pharmaceutical giant ...

As the World Health Organization conditionally recommends the use of GLP-1 medications to treat obesity, a Halifax-based ...

One of largest U.S. telehealth providers expects to ride wave of exploding demand for weight-loss drug semaglutide when it ...

Melissa McCarthy debuted a visibly slimmer physique while hosting Saturday Night Live Dec. 6, with many fans complimenting ...

OneSource anticipates leading the generics market for semaglutide as multiple patents expire, expanding its capacity and ...

The World Health Organization has issued its first guidelines for the use of GLP-1s, such as Ozempic, to treat obesity. The ...

Scientists are testing a GLP-1-based injection, similar to Ozempic, to see whether it can help overweight cats manage obesity ...

If you visit a fast-food chain in the next few years, expect the menu to look a little less gluttonous.

The success of semaglutide and tirzepatide is evident in their 2024 sales volumes and revenues, creating a clearer picture of ...

If you visit a fast-food chain in the next few years, expect the menu to look a little less gluttonous. (Nov. 30, 2025) ...

India’s pharmaceutical giants are hoping to earn fat profits as their customers get thinner. With the patent for blockbuster diabetes and weight-loss drugs Ozempic and Wegovy set to expire in March, ...

Taking a GLP-1 medication? A guide for what to avoid during the holiday season — and how to still enjoy dessert ...